← Open Payments lookup

MATTHEW BZDYK: Open Payments

NPI 1528843182 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,319 in 62 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,004 · 2025 $1,319

Food & beverage: $1,319
CompanyPaymentsAmount
Janssen Biotech, Inc.10$265
ABBVIE INC.13$213
Ardelyx, Inc.6$146
Takeda Pharmaceuticals U.S.A., Inc.4$100
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$94
Ipsen Biopharmaceuticals, Inc4$87
Madrigal Pharmaceuticals3$85
Aimmune Therapeutics, Inc.3$51
Lilly USA, LLC2$49
Gilead Sciences, Inc.2$34

Products named: TREMFYA, IBSRELA, RINVOQ, ENTYVIO, XIFAXAN, IQIRVO, REZDIFFRA, LINZESS.

Industry payments across AZ — which companies pay providers there.